{"date":"2026-01-26","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4728-2026-01-26-2205-38ffrd","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"22:05:24","subject":"公告本公司獨立董事對審計委員會及董事會決議事項表示反對意見。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-01-26 22:05，「公告本公司獨立董事對審計委員會及董事會決議事項表示反對意見。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-01-26-2203-pt257j","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"22:03:58","subject":"公告本公司董事會通過執行副總經理任用案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-01-26 22:03，「公告本公司董事會通過執行副總經理任用案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-01-26-2002-s83qt4","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-26","time":"20:02:49","subject":"公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-01-26 20:02，「公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-01-26-1835-75vc3q","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-01-26","time":"18:35:26","subject":"公告本公司114年度現金增資認股基準日暨相關事宜(更正畸零股之處理方式)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-01-26 18:35，「公告本公司114年度現金增資認股基準日暨相關事宜(更正畸零股之處理方式)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-01-26-1748-1dd9qx8","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"17:48:04","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-01-26 17:48，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-01-26-1740-15pwwnw","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-26","time":"17:40:49","subject":"公告本公司皮下填補劑通過ISO13485醫療器材品質系統認證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-01-26 17:40，「公告本公司皮下填補劑通過ISO13485醫療器材品質系統認證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-01-26-1736-1ejtzv5","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-26","time":"17:36:20","subject":"本公司研發之利用自體培養之EB病毒專一性毒殺T細胞對鼻咽癌病患所進行之免疫療法「EBaT8」，向台灣衛生福利部食品藥物管理署（TFDA）提出第一跨二a期臨床試驗申請。","clause":"第44款","fact_date":"2026-01-26","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-01-26 17:36，「本公司研發之利用自體培養之EB病毒專一性毒殺T細胞對鼻咽癌病患所進行之免疫療法「EBaT8」，向台灣衛生福利部食品藥物管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-01-26-1734-1rxws49","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-01-26","time":"17:34:53","subject":"公告本公司一針劑型及三針劑型透明質酸”Hyaflex Forte”、”Hyaflex”關節腔注射劑產品取得銷售許可證書","clause":"第51款","fact_date":"2026-01-26","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-01-26 17:34，「公告本公司一針劑型及三針劑型透明質酸”Hyaflex Forte”、”Hyaflex”關節腔注射劑產品取得銷售許可證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-01-26-1716-1hu3cbe","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"17:16:21","subject":"本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-01-26 17:16，「本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-01-26-1715-19hk16w","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"17:15:57","subject":"公告本公司董事會通過解除經理人競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-01-26 17:15，「公告本公司董事會通過解除經理人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-01-26-1715-1owutbe","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"17:15:37","subject":"公告本公司董事會通過新任副總經理追認案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-01-26 17:15，「公告本公司董事會通過新任副總經理追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-01-26-1614-18an8s8","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-01-26","time":"16:14:04","subject":"本公司115年2月6日受邀參加元大證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-01-26 16:14，「本公司115年2月6日受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-01-26-1544-d0rieh","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-01-26","time":"15:44:30","subject":"本公司114年現金增資催繳期間屆滿暨股票發放事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-01-26 15:44，「本公司114年現金增資催繳期間屆滿暨股票發放事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-01-26-1500-1gvae3q","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-26","time":"15:00:22","subject":"代子公司太景生物科技股份有限公司公告董事會通過並完成與Boryung Biopharma Co. Ltd.簽署「Pixavir marboxil(TG-1000)授權協議」","clause":"第10款","fact_date":"2026-01-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-01-26 15:00，「代子公司太景生物科技股份有限公司公告董事會通過並完成與Boryung Biopharma Co. Ltd.簽署「Pixa」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-01-26-1430-lofswb","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-01-26","time":"14:30:54","subject":"本公司受邀參加高盛(Goldman Sachs)舉辦之「Non-Deal Roadshow」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-01-26 14:30，「本公司受邀參加高盛(Goldman Sachs)舉辦之「Non-Deal Roadshow」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-01-26-1341-1l248wr","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-01-26","time":"13:41:29","subject":"公告本公司114年現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-01-26 13:41，「公告本公司114年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-01-26-1147-whmssg","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-01-26","time":"11:47:40","subject":"公告本公司114年度現金增資認股基準日暨相關事宜(更正原股東每仟股認股率)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-01-26 11:47，「公告本公司114年度現金增資認股基準日暨相關事宜(更正原股東每仟股認股率)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}